Aclaris Therapeutics Inc (ACRS): Insights At A Glance

Aclaris Therapeutics Inc (ACRS) concluded trading on Wednesday at a closing price of $1.32, with 3.53 million shares of worth about $4.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.79% during that period and on July 17, 2024 the price saw a […]

Analysts Update Their Price Forecasts For Aclaris Therapeutics Inc (ACRS)

Aclaris Therapeutics Inc (ACRS) concluded trading on Wednesday at a closing price of $1.06, with 5.19 million shares of worth about $5.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -87.76% during that period and on Wednesday February 7 the price saw a […]

Aclaris Therapeutics Inc (NASDAQ: ACRS): Do Not Miss The Gain Train

BVF Partners LP has recently announced that it has increased stake in Aclaris Therapeutics Inc (NASDAQ:ACRS) by 110.20%. After grabbing 7.06 million shares, the institutional investor is now in possession of 3.7 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.97% having worth around $6.18 million. Moreover, […]

Look For Institutional Buying In Aclaris Therapeutics Inc (NASDAQ: ACRS)

BVF Partners LP has recently announced that it has increased stake in Aclaris Therapeutics Inc (NASDAQ:ACRS) by 110.20%. After grabbing 7.06 million shares, the institutional investor is now in possession of 3.7 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.97% having worth around $6.18 million. Moreover, […]

Now Is A Suitable Moment For A Long-Term Purchase Of Aclaris Therapeutics Inc (NASDAQ: ACRS)

BVF Partners LP recently announced the acquisition of new stake in Aclaris Therapeutics Inc (NASDAQ:ACRS). The institutional investor has increased its shareholding in the Healthcare company by 110.20% to 7.06 million shares with purchase of 3.7 million shares. This fresh investment now brings its stake to 9.98% valued currently at $35.18 million. In addition, BlackRock […]

Tomorrow Is Not Likely To Be Same For Aclaris Therapeutics Inc (ACRS)

BVF Partners LP has recently announced that it has increased stake in Aclaris Therapeutics Inc (NASDAQ:ACRS) by 110.20%. After grabbing 7.06 million shares, the institutional investor is now in possession of 3.7 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.98% having worth around $35.18 million. Moreover, […]

Aclaris Therapeutics Inc (NASDAQ: ACRS) Is Getting Increasingly Hard To Ignore

BVF Partners LP recently announced the acquisition of new stake in Aclaris Therapeutics Inc (NASDAQ:ACRS). The institutional investor has increased its shareholding in the Healthcare company by 110.20% to 7.06 million shares with purchase of 3.7 million shares. This fresh investment now brings its stake to 9.98% valued currently at $35.18 million. In addition, BlackRock […]